Search results
Novo Nordisk announces $6B investment in Ozempic, Wegovy amid shortages
Good Morning America via Yahoo News· 2 days agoNovo Nordisk, the maker of popular drugs used for weight loss including Ozempic and Wegovy, says it...
When supplies resume, should governments subsidise drugs like Ozempic for weight loss? We asked 5...
The Conversation· 6 days agoNeither Ozempic nor Wegovy are listed on the PBS to treat obesity. When Wegovy becomes available, users will need to pay the full price. Or should the government subsidise it?
Novo Nordisk A/S (NYSE:NVO) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 24 hours agoNovo Nordisk A/S (NYSE:NVO) Q1 2024 Earnings Call Transcript May 2, 2024 Novo Nordisk A/S misses on...
Eli Lilly (LLY) Q1 Earnings Top, Sales Miss, 2024 View Raised
Zacks via Yahoo Finance· 4 days agoEli Lilly (LLY) beats first-quarter estimates for earnings but misses the same for sales. It raises...
Novo Nordisk Investing $6 Billion to Increase Access to Ozempic and Wegovy amid Nationwide Shortage
People via Yahoo Finance· 2 days ago“We agree that these medications need to be more affordable — that’s a stake that we’ve put in the...
Should You Invest in Novo Nordisk (NVO) Ahead of Q1 Earnings?
Zacks via Yahoo Finance· 5 days agoNovo Nordisk's (NVO) revenues in the first quarter of 2024 are expected to have been driven by its...
The Ozempic Effect: How a Weight Loss Wonder Drug Gobbled Up an Entire Economy
Bloomberg via Yahoo Finance· 3 days ago(Bloomberg) -- There is no escaping Ozempic and Wegovy. The diabetes and obesity drugs are a global...
Regeneron’s stock rallies as pipeline prospects outweigh earnings miss
Market Watch· 2 days agoThe revenue shortfall was partly due to a decline in sales of the company’s blockbuster eye drug...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
NBC Washington· 4 days agoFederal regulators are challenging patents on 20 brand name drugs, including the blockbuster...
The top pharmaceutical companies by R&D expenditure
Pharmaceutical Technology via Yahoo Finance· 3 days agoMoving forward, Eli Lilly’s R&D efforts are focused on building a pipeline of assets that can reduce muscle loss associated with incretin medications...
